Viread and hepatitis B: what should you know?

Chronic hepatitis B can remain quiet while still affecting the liver, so symptoms do not show the whole picture. Fatigue or dark urine may occur, but some people notice no warning signs. Viread can reduce viral activity; it does not remove the need for follow-up or automatically mean treatment can stop. Clinicians consider liver inflammation, viral testing, kidney health, other medicines and pregnancy plans when reviewing therapy. A liver function test is one part of this monitoring.

Take Viread exactly as prescribed and do not stop it suddenly without medical advice, because hepatitis B activity can increase after treatment changes. Tell your clinician about kidney problems, bone concerns, pregnancy or breastfeeding, and every medicine or supplement you use. Keep appointments for blood tests and discuss alcohol, household transmission prevention and vaccination for eligible close contacts. Do not share tablets or use someone else's prescription.

Contact your clinician promptly for yellowing of the skin or eyes, worsening dark urine, severe abdominal swelling, confusion, vomiting that prevents medicines, or a major decline in energy. Seek urgent help for severe illness or confusion. Arrange review before running out of tablets or if side effects affect your ability to continue treatment.

Ask why Viread is recommended, which blood tests will be followed, how kidney and bone health will be checked, and what to do after a missed dose. Ask whether household contacts need hepatitis B vaccination and how pregnancy plans affect treatment.